Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Alembic Pharmaceutica
Since it’s an ingredient in so many foods, you h
In a world constantly in motion, Microbioz India r
The World Health Organization said on Wednesday that its experts were still reviewing safety data on the AstraZeneca COVID-19 vaccine following concerns around blood clots but advocated that injection programs continue.
While millions of doses of the vaccine have been administered, small numbers of people have developed blood clots, prompting nations such as the EU’s three biggest countries — Germany, France and Italy — to suspend shots.
“The WHO Global Advisory Committee on Vaccine Safety is carefully analyzing the newest available safety data,” the UN health agency said in a statement.
“At this time, WHO believes that the benefits of the AstraZeneca vaccine outweigh its risks and urges that vaccinations continue.”
It said that once the committee had finished its review, the WHO would immediately communicate its findings.
The WHO said that in mass vaccination campaigns, it was routine for countries to flag potential adverse events after individuals have been immunised.
“This does not necessarily mean that the events are linked to vaccination itself, but it’s good practice to research them. It also proves that the surveillance system works and that effective controls are in place,” it said.
“Vaccination against COVID-19 won’t reduce illness or deaths from other causes.
“Thromboembolic events are known to occur frequently. Venous thromboembolism is the third most common cardiovascular disease worldwide.”
The WHO said it had been in regular contact with the EU’s European Medicines Agency and regulators across the world for the latest information on COVID-19 vaccine security.
